NPC leader tours WuXi PharmaTech
Dec 22, 2005
December 22, 2005 - Shanghai, China - Mr. Xu Jialu, Vice Chairman of the National People's Congress, visited WuXi PharmaTech Co., Ltd. in Pudong on Tuesday and spoke highly about the company's rapid growth and development strategy.
Founded in 2001, WuXi PharmaTech is the leading provider of chemistry R&D and manufacturing services to global life science companies. The company's customers include 18 of the top 20 pharmaceutical companies and 8 of the top 10 biopharmaceutical companies in the world.
From 2001 to 2005, WuXi PharmaTech grew more than 100 times in revenue, enjoying a three-digit revenue growth year over year and staff expansion from fewer than 20 people to more than 900 today.
The company was ranked 9th among the Deloitte Technology Fast 500 Asia Pacific competition in 2004 and voted one of Red Herring Asia 100 private enterprises this year. Red Herring is an influential weekly magazine for technology entrepreneurs, investors and industry observers.
Dr. Li Ge, the founder and CEO of WuXi PharmaTech, said the company's goal is to become a world-class drug discovery and development service provider.
Dr. Li is a graduate of Beijing University and obtained his Ph.D. in organic chemistry from Columbia University. He was one of the founding scientists of the NASDAQ-listed Pharmacopeia, Inc. in Princeton, New Jersey, and he is the co-owner of a number of US patents. In September this year he received the Outstanding Entrepreneur Award from the Overseas Chinese Affairs Office of the State Council.
WuXi PharmaTech currently has 700 scientists, a state-of-the-art research center, a bioanalytical laboratory, and a 250, 000 sq.ft. cGMP pharmaceutical ingredient manufacturing plant in Shanghai's Jinshan District.
As a quality and customer satisfaction-driven company, WuXi PharmaTech offers global drug makers diverse and integrated outsourcing services, including drug lead discovery, medicine chemistry, chemical process development, analytical and bioanalytical chemistry and GMP manufacturing.
Led by a business-savvy and Western-trained management team, WuXi PharmaTech has attracted many young professionals from home and abroad. The company has earned the trust of patent-sensitive clients by implementing a unique intellectual property protection system.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.